Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 298.30M P/E - EPS this Y 47.70% Ern Qtrly Grth -
Income -72.73M Forward P/E -1.66 EPS next Y -20.60% 50D Avg Chg -19.00%
Sales 15.73M PEG -0.04 EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 1.73 EPS next 5Y 21.22% 52W High Chg -47.00%
Recommedations 2.70 Quick Ratio 4.20 Shares Outstanding 192.87M 52W Low Chg 37.00%
Insider Own - ROA -22.25% Shares Float 43.34M Beta 0.76
Inst Own 19.63% ROE -43.47% Shares Shorted/Prior 524.49K/548.09K Price 1.48
Gross Margin 100.00% Profit Margin - Avg. Volume 240,648 Target Price 4.93
Oper. Margin -134.32% Earnings Date Jul 29 Volume 450,974 Change -8.07%
About DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

DBV Technologies S.A. News
04/25/24 Combined General Meeting of May 16, 2024
04/04/24 Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
03/08/24 DBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call Transcript
03/08/24 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
03/07/24 DBV Technologies Reports Full Year 2023 Financial Results and Business Update
03/04/24 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
02/20/24 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
01/16/24 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
12/04/23 Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023
11/09/23 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
11/06/23 Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
03:30 PM DBV Technologies to Present New Data at ACAAI 2023
11/01/23 DBV Technologies S.A. (NASDAQ:DBVT) Q3 2023 Earnings Call Transcript
10/31/23 DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
10/27/23 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
10/16/23 DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
10/05/23 Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
09/05/23 DBV Technologies to Participate in Upcoming Investor Conference
07/31/23 DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
07/25/23 DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
DBVT Chatroom

User Image ToTheStarsTwits Posted - 6 hours ago

$DBVT no one else here? Let's go folks

User Image ToTheStarsTwits Posted - 04/29/24

$DBVT

User Image Stock_Titan Posted - 04/25/24

$DBVT Combined General Meeting of May 16, 2024 https://www.stocktitan.net/news/DBVT/combined-general-meeting-of-may-16-bakk50dx83km.html

User Image Billianas Posted - 04/25/24

$DBVT RS coming soon, probably 1 to 5. We could see 0,4$ - 0,5$ keep it on watch

User Image a36er Posted - 04/24/24

$DBVT Market makers are trading this really odd. Fills are taking forever...with my limited novice experience... this normally indicates look out below.

User Image ToTheStarsTwits Posted - 04/23/24

$DBVT earnings week started strong... Let's see this march up and finish this week strong

User Image kriks2611 Posted - 04/22/24

$DBVT... 😴

User Image ToTheStarsTwits Posted - 04/05/24

$DBVT great finish today... Let's please see some nice continuation up next week

User Image CocaKolla Posted - 04/05/24

$DBVT back in play

User Image ToTheStarsTwits Posted - 04/05/24

$DBVT adding

User Image TheDipMaster Posted - 04/04/24

$DBVT .7 looks good. Double bottom looks like

User Image Stock_Titan Posted - 04/04/24

$DBVT Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 https://www.stocktitan.net/news/DBVT/information-regarding-the-total-number-of-voting-rights-and-total-dvm7xvppydbx.html

User Image vaselineguy Posted - 04/03/24

$DBVT time to buy here. Don't be late.

User Image vaselineguy Posted - 1 month ago

$DBVT coming

User Image MaVwapMacd Posted - 1 month ago

$DBVT 30% of the desired position for a swing above $1

User Image vaselineguy Posted - 03/22/24

$DBVT it will happens.

User Image vaselineguy Posted - 03/15/24

$DBVT no problem

User Image fda_tracker Posted - 03/13/24

$DBVT Phase 2 trial w/est Mar completion date NCT04492683: https://www.clinicaltrials.gov/study/NCT04492683 Trial Tracker: https://www.fdatracker.com/trial-tracker/

User Image vaselineguy Posted - 03/13/24

$DBVT grabbed big

User Image Kylian7 Posted - 03/12/24

$DBVT The CEO just purchased shares (for the first time) at yesterday's opening session ($0.83). It's a very interesting signal of his confidence in the project.

User Image BioSense Posted - 03/08/24

$DBVT anyone listen to the earnings call? What was the business update?

User Image Stock_Titan Posted - 03/08/24

$DBVT DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document https://www.stocktitan.net/news/DBVT/dbv-technologies-announces-filing-of-2023-annual-report-on-form-10-k-lxs5x5zfiws4.html

User Image Stock_Titan Posted - 03/07/24

$DBVT DBV Technologies Reports Full Year 2023 Financial Results and Business Update https://www.stocktitan.net/news/DBVT/dbv-technologies-reports-full-year-2023-financial-results-and-icybyqhtcaus.html

User Image BabyGangsterAX Posted - 03/07/24

$dbvt dont worrry.. it will go over 1

User Image Stock_Titan Posted - 03/04/24

$DBVT DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 https://www.stocktitan.net/news/DBVT/dbv-technologies-to-report-full-year-2023-financial-results-and-98xgbssntbed.html

User Image GetTheseTendies Posted - 02/26/24

$DBVT going to start a position after earnings glta

User Image BabyGangsterAX Posted - 02/21/24

$DBVT $ALLK Never Sell it.. it is slow but it will move ... Buy and Hold

User Image BabyGangsterAX Posted - 02/21/24

$DBVT dont worry... if down 20-25% then avg down..

User Image Stock_Titan Posted - 02/20/24

$DBVT DBV Technologies to Participate in Upcoming AAAAI 2024 Congress https://www.stocktitan.net/news/DBVT/dbv-technologies-to-participate-in-upcoming-aaaai-2024-hqg10r5j9w5j.html

User Image Aigner_Andreas Posted - 02/15/24

TF SELL $DBVT at 0.85 : 0.85 MicroCap -26% Shp 1.23 S 1.7 N 0.38 RSI 44.19% SRSI 2.26% ADXR 17.37 #stocks #trading #finance #market

Analyst Ratings
HC Wainwright & Co. Buy Feb 21, 24
HC Wainwright & Co. Buy Nov 13, 23
Goldman Sachs Sell Nov 2, 23
JMP Securities Market Outperform Aug 1, 23
HC Wainwright & Co. Buy Aug 1, 23
JMP Securities Market Outperform May 11, 23
HC Wainwright & Co. Buy May 9, 23
JMP Securities Market Outperform May 5, 23
JMP Securities Market Outperform Apr 27, 23